Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M211Revenue $M1.1Net Margin (%)-1,702.4Z-Score-22.7
Enterprise Value $M225EPS $-0.4Operating Margin %-1,476.2F-Score4
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-1,702.4Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio3.0Cash flow > EarningsY
Price/Sales70.05-y EBITDA Growth Rate %59.1Current Ratio3.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-132.4Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M151ROI % (ttm)-168.4Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

NAVB is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Nordlicht Mark10% Owner 2014-09-02Sell60,000$1.362.94 view
Regan William J.SVP-Global Reg Affairs&Quality 2014-05-12Buy5,000$1.43-2.1 view
PYKETT MARK JEROMECEO 2014-05-09Buy10,000$1.344.48 view
Cope Frederick OSVP 2014-03-10Sell15,000$1.96-28.57 view
LARSON BRENT LEVP, CFO, Treas & Secy 2014-03-10Sell41,500$1.96-28.57 view
PYKETT MARK JEROMECEO 2014-03-10Sell120,000$1.96-28.57 view
FORD BRENDAN ADirector 2013-11-08Buy20,000$1.45-3.45 view
LARSON BRENT LEVP, CFO, Treas & Secy 2013-11-08Buy5,000$1.390.72 view
PYKETT MARK JEROMECEO 2013-11-08Buy10,900$1.353.7 view
Cope Frederick OSVP 2013-11-08Buy3,500$1.43-2.1 view

Press Releases about NAVB :

    Quarterly/Annual Reports about NAVB:

    News about NAVB:

    Articles On GuruFocus.com
    Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 
    comment on NAVB Mar 15 2013 

    More From Other Websites
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 16 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 15 2014
    Navidea Announces Rick Gonzalez as New Chief Executive Officer Oct 15 2014
    Navidea Announces Rick Gonzalez as New Chief Executive Officer Oct 15 2014
    FDA Approves Expanded Use of Navidea’s Lymphoseek® for Lymphatic Mapping in Solid Tumors Oct 15 2014
    FDA Approves Expanded Use of Navidea’s Lymphoseek® for Lymphatic Mapping in Solid Tumors Oct 15 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Oct 01 2014
    Navidea to Participate in the BTIG Emerging Technologies in Healthcare Diagnostics Investor... Sep 29 2014
    Navidea’s Lymphoseek® Recommended by CHMP for European Approval in Sentinel Lymph Node Detection... Sep 26 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 24 2014
    Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of Lymphoseek® in Cervical Cancer Sep 23 2014
    Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck Cancers Sep 18 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 10 2014
    Should Navidea Biopharmaceuticals (NAVB) Be On Your Radar Now? Sep 10 2014
    Navidea Enters Lymphoseek® Development and Commercialization Agreement for China Sep 04 2014
    Navidea Enters Lymphoseek® Development and Commercialization Agreement for China Sep 04 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Financials Aug 19 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 11 2014
    NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
    Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today Aug 06 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK